NextCure, Inc.

Analysis for Ticker: NXTC

NextCure Inc is a clinical stage biotechnology company that searches for new ways to treat cancer by studying how the immune system interacts with tumors. The business sounds like a miracle but the internal math is a disaster. They have never sold a single product or made a dollar of revenue yet they have already spent 436,0$ million of other people's money. It is like a person who buys a mansion with a credit card and starts selling the windows and doors to pay the interest while the roof is already on fire.